Lundbeck A/S
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.
Beyond's analysis on Lundbeck A/S
- — Lundbeckfond Invest launches voluntary A‑share exchange offer to increase its stake in H. Lundbeck
- — Lundbeckfond Invest launches a voluntary exchange offer to acquire A-shares in H. Lundbeck, seeking to increase its stake